Warner-Lambert To Set Up JV In Turkey

Turkey's Eczacibasi Medicine Group and Warner-Lambert of the USA, havesigned an agreement for the establishment in Turkey of a joint venture for the production of pharmaceuticals, according to the EBA Newsletter. The two companies have a history of cooperation in the drug area dating back to 1952.

Under the agreement, some of W-L's leading over-the-counter and prescription medicines will be produced at Eczacibasi's production plant at Luleburgaz in north-western Turkey. Eczacibasi aims to increase its annual sales volume to $20 million a year within the next three years following its deal with W-L.

Ambitions In India Meantime, W-L's Parke-Davis (India) Ltd unit expects to double its turnover - now 176 million rupees ($4.9 million) - over three years through acquisitions, including a major antibiotic brand within the next six months. The plan also includes launching brands owned by its parent, W-L.